BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24800836)

  • 21. Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node.
    Nadkarni JJ; Perambakam SM; Rathore VB; Amin KM; Parikh PM; Naresh KN; Advani SH
    Cancer Biother Radiopharm; 1998 Aug; 13(4):269-74. PubMed ID: 10850362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
    Fedorchenko O; Stiefelhagen M; Peer-Zada AA; Barthel R; Mayer P; Eckei L; Breuer A; Crispatzu G; Rosen N; Landwehr T; Lilienthal N; Möllmann M; Montesinos-Rongen M; Heukamp L; Dürig J; Hallek M; Fingerle-Rowson G; Herling M
    Blood; 2013 May; 121(20):4126-36. PubMed ID: 23547049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Lymphocytic Leukemia: Disease Biology.
    Koehrer S; Burger JA
    Acta Haematol; 2024; 147(1):8-21. PubMed ID: 37717577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.
    Herndon TM; Chen SS; Saba NS; Valdez J; Emson C; Gatmaitan M; Tian X; Hughes TE; Sun C; Arthur DC; Stetler-Stevenson M; Yuan CM; Niemann CU; Marti GE; Aue G; Soto S; Farooqui MZH; Herman SEM; Chiorazzi N; Wiestner A
    Leukemia; 2017 Jun; 31(6):1340-1347. PubMed ID: 28074063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.
    Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J
    Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment.
    Chen Z; Simon-Molas H; Cretenet G; Valle-Argos B; Smith LD; Forconi F; Schomakers BV; van Weeghel M; Bryant DJ; van Bruggen JAC; Peters FS; Rathmell JC; van der Windt GJW; Kater AP; Packham G; Eldering E
    Blood; 2022 Aug; 140(6):630-643. PubMed ID: 35486832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.
    Sun C; Chen YC; Martinez Zurita A; Baptista MJ; Pittaluga S; Liu D; Rosebrock D; Gohil SH; Saba NS; Davies-Hill T; Herman SEM; Getz G; Pirooznia M; Wu CJ; Wiestner A
    Blood Adv; 2023 Jan; 7(1):145-158. PubMed ID: 35358998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
    Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
    Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
    Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
    Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.
    Dadashian EL; McAuley EM; Liu D; Shaffer AL; Young RM; Iyer JR; Kruhlak MJ; Staudt LM; Wiestner A; Herman SEM
    Cancer Res; 2019 Jan; 79(2):360-371. PubMed ID: 30498085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
    Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
    Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
    Krenn PW; Hofbauer SW; Pucher S; Hutterer E; Hinterseer E; Denk U; Asslaber D; Ganghammer S; Sternberg C; Neureiter D; Aberger F; Wickström SA; Egle A; Greil R; Hartmann TN
    Cancer Res; 2016 Apr; 76(8):2186-96. PubMed ID: 26837762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in vivo.
    Lafouresse F; Bellard E; Laurent C; Moussion C; Fournié JJ; Ysebaert L; Girard JP
    Blood; 2015 Sep; 126(11):1336-45. PubMed ID: 26162407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
    Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
    Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
    Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
    Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
    Lorenzo-Herrero S; Sordo-Bahamonde C; Bretones G; Payer ÁR; González-Rodríguez AP; González-García E; Pérez-Escuredo J; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S; López-Soto A
    Front Immunol; 2019; 10():2455. PubMed ID: 31681329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice.
    Collard JP; McKenna MK; Noothi SK; Alhakeem SS; Rivas JR; Rangnekar VM; Muthusamy N; Bondada S
    Leuk Lymphoma; 2022 Aug; 63(8):1810-1822. PubMed ID: 35258388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.